ResearcherTranslational Genomics Research InstituteActive in the last 2 years

Lin Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7146-891X; OpenAlex author ID A5006470567. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 14

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kuntal Halder · 1 shared paper, 2025 · strength 0.21
- Paper Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-025-03167-2 ↗
Mitsuro Kanda · 1 shared paper, 2025 · strength 0.21
- Paper Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-025-03167-2 ↗
Derek Cridebring · 1 shared paper, 2025 · strength 0.21
- Paper Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-025-03167-2 ↗
Haruyoshi Tanaka · 1 shared paper, 2025 · strength 0.21
- Paper Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-025-03167-2 ↗
Gayle Jameson · 1 shared paper, 2025 · strength 0.21
- Paper Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-025-03167-2 ↗
Mohammed Aldakkak · 1 shared paper, 2025 · strength 0.21
- Paper Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-025-03167-2 ↗
Douglas B. Evans · 1 shared paper, 2025 · strength 0.21
- Paper Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-025-03167-2 ↗
Haiyong Han · 1 shared paper, 2025 · strength 0.21
- Paper Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-025-03167-2 ↗
Susan Tsai · 1 shared paper, 2025 · strength 0.21
- Paper Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-025-03167-2 ↗
Erkut Hasan Borazanci · 1 shared paper, 2025 · strength 0.21
- Paper Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-025-03167-2 ↗
Ajay Goel · 1 shared paper, 2025 · strength 0.21
- Paper Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-025-03167-2 ↗
Daniel D. Von Hoff · 1 shared paper, 2025 · strength 0.21
- Paper Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-025-03167-2 ↗
Lei Li · 1 shared paper, 2015 · strength 0.06
- Paper Role of vitamin D receptor gene polymorphisms in pancreatic cancer: a case-control study in China. DOI 10.1007/s13277-015-3119-6 ↗
Weihui Zhang · 1 shared paper, 2015 · strength 0.06
- Paper Role of vitamin D receptor gene polymorphisms in pancreatic cancer: a case-control study in China. DOI 10.1007/s13277-015-3119-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.